Carregant...
Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker Evaluation
Recent advances in biotechnology and cancer genomics have afforded enormous opportunities for development of more effective anticancer therapies. A key thrust of this modern drug development paradigm is successful identification of predictive biomarkers that can distinguish patients who might be sen...
Guardat en:
| Publicat a: | JCO Precis Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Clinical Oncology
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7446320/ https://ncbi.nlm.nih.gov/pubmed/32923845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00416 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|